Webinar Recording: A Structured Approach to T2DM in Private Practice - Oral and Non-Insulin Injectable Therapies (2 CPD Points)

Important:

To activate your one-week access to the webinar recording and claim your 2 CPD points, please forward your Quicket ticket as proof of purchase to [email protected].

BONUS Access:

Be sure to include your WhatsApp number in the email to gain exclusive entry into our whatsapp group with Dr. Mahlasela, our private expert physician. This group offers continuous learning, ongoing support, and the opportunity to ask advice or follow up with questions after the webinar.

Access will be granted instantly from the date of purchase.

Bridging the gap between public training and private practice

Stepping into private practice and suddenly facing dozens of medications you’ve never prescribed before?

New brands.

New combinations.

New pricing tiers.

And patients expect you to know them all.

Most doctors learn the hard way.

You don’t have to.

Why Uptomed?

Uptomed webinars are led by private practice healthcare experts with decades of real-world experience.

We break down the wide variety of private-sector drugs not available in the public sector into clear, practical prescribing knowledge, so you’re never caught off guard in front of a patient.

We simplify the overload, one focused webinar at a time.

Upcoming Focus

Type 2 diabetes management has evolved far beyond metformin and insulin. With a growing range of oral and non-insulin injectable therapies many offering proven cardiovascular and renal benefits, clinicians need a practical, structured approach to selecting the right treatment for each patient.

This webinar is designed to close that gap with a structured, guideline-anchored approach, rooted in SEMDSA 2017 and aligned with current ADA/EASD thinking, supported by clinical scenarios to aid progression from monotherapy to dual, triple, and complex therapy. You’ll gain a practical understanding of the mechanism of action, dosing, side effects, and contraindications of metformin, gliclazide MR, pioglitazone, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists.

We will also explore which patients should be prioritised for SGLT2 inhibitors and GLP-1 receptor agonists based on the latest cardiovascular and renal outcome data and ADA/EASD recommendations.

Designed specifically for doctors transitioning into private practice, this session will help you avoid common prescribing pitfalls and give you the confidence to manage T2DM using the full spectrum of therapies available in the South African private sector."

Unlock The Recording

Step confidently into private practice with this essential webinar recording.

This recording is more than just a replay. It's a toolkit for success in private practice. By purchasing access, you’ll equip yourself with the knowledge to close the training gap and elevate your dermatological care.